236 related articles for article (PubMed ID: 23831596)
1. Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.
Périé S; Trollet C; Mouly V; Vanneaux V; Mamchaoui K; Bouazza B; Marolleau JP; Laforêt P; Chapon F; Eymard B; Butler-Browne G; Larghero J; St Guily JL
Mol Ther; 2014 Jan; 22(1):219-25. PubMed ID: 23831596
[TBL] [Abstract][Full Text] [Related]
2. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
[TBL] [Abstract][Full Text] [Related]
3. Cricopharyngeal myotomy in the treatment of oculopharyngeal muscular dystrophy.
Gómez-Torres A; Abrante Jiménez A; Rivas Infante E; Menoyo Bueno A; Tirado Zamora I; Esteban Ortega F
Acta Otorrinolaringol Esp; 2012; 63(6):465-9. PubMed ID: 22898142
[TBL] [Abstract][Full Text] [Related]
4. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of oculopharyngeal dystrophy: a report of three cases from the same family.
Munitiz V; Ortiz A; Martinez de Haro LF; Glover G; Ferri B; Montoya M; Parrilla P
Dis Esophagus; 2003; 16(2):160-4. PubMed ID: 12823221
[TBL] [Abstract][Full Text] [Related]
6. A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD).
Waito AA; Steele CM; Peladeau-Pigeon M; Genge A; Argov Z
Dysphagia; 2018 Dec; 33(6):789-802. PubMed ID: 29725764
[TBL] [Abstract][Full Text] [Related]
7. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
[TBL] [Abstract][Full Text] [Related]
8. Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
[TBL] [Abstract][Full Text] [Related]
9. Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.
Manjaly JG; Vaughan-Shaw PG; Dale OT; Tyler S; Corlett JC; Frost RA
Dysphagia; 2012 Jun; 27(2):216-20. PubMed ID: 21805106
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of cricopharyngeal myotomy in oculopharyngeal muscular dystrophy.
Coiffier L; Périé S; Laforêt P; Eymard B; St Guily JL
Otolaryngol Head Neck Surg; 2006 Aug; 135(2):218-22. PubMed ID: 16890071
[TBL] [Abstract][Full Text] [Related]
11. PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
Malerba A; Klein P; Bachtarzi H; Jarmin SA; Cordova G; Ferry A; Strings V; Espinoza MP; Mamchaoui K; Blumen SC; St Guily JL; Mouly V; Graham M; Butler-Browne G; Suhy DA; Trollet C; Dickson G
Nat Commun; 2017 Mar; 8():14848. PubMed ID: 28361972
[TBL] [Abstract][Full Text] [Related]
12. Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
Rüegg S; Lehky Hagen M; Hohl U; Kappos L; Fuhr P; Plasilov M; Müller H; Heinimann K
Swiss Med Wkly; 2005 Oct; 135(39-40):574-86. PubMed ID: 16333769
[TBL] [Abstract][Full Text] [Related]
13. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
Malerba A; Klein P; Lu-Nguyen N; Cappellari O; Strings-Ufombah V; Harbaran S; Roelvink P; Suhy D; Trollet C; Dickson G
Hum Mol Genet; 2019 Oct; 28(19):3301-3308. PubMed ID: 31294444
[TBL] [Abstract][Full Text] [Related]
14. Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy.
Harish P; Malerba A; Dickson G; Bachtarzi H
Hum Gene Ther; 2015 May; 26(5):286-92. PubMed ID: 25860803
[TBL] [Abstract][Full Text] [Related]
15. Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland.
Agarwal PK; Mansfield DC; Mechan D; Al-Shahi Salman R; Davenport RJ; Connor M; Metcalfe R; Petty R
Br J Ophthalmol; 2012 Feb; 96(2):281-3. PubMed ID: 21602480
[TBL] [Abstract][Full Text] [Related]
16. Dysphagia in oculopharyngeal muscular dystrophy: a series of 22 French cases.
Périé S; Eymard B; Laccourreye L; Chaussade S; Fardeau M; Lacau St Guily J
Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S96-9. PubMed ID: 9392025
[TBL] [Abstract][Full Text] [Related]
17. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
[TBL] [Abstract][Full Text] [Related]
18. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
[TBL] [Abstract][Full Text] [Related]
19. Manometric and radionuclide assessment of pharyngeal emptying before and after cricopharyngeal myotomy in patients with oculopharyngeal muscular dystrophy.
Taillefer R; Duranceau AC
J Thorac Cardiovasc Surg; 1988 May; 95(5):868-75. PubMed ID: 3361934
[TBL] [Abstract][Full Text] [Related]
20. Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy.
de Swart BJ; van der Sluijs BM; Vos AM; Kalf JG; Knuijt S; Cruysberg JR; van Engelen BG
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):266-8. PubMed ID: 16421137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
